NSE: ASTRAZEN | BSE: 506820

Expensive Performer

Download real time

7943.00 -3.50 (-0.04%)

3,031 NSE+BSE Volume

NSE 12 Aug, 2026 2:19 PM (IST)

19,857.5

Market Cap

High in industry

Beta 1Year

Very Low volatility

Margin Decline

AstraZeneca Pharma's Q1 EBITDA margin drops 830 bps YoY on higher inventory, staff & selling costs See details

AstraZeneca Pharma India Ltd. share price target and research reports

Name: Latest research reports of AstraZeneca Pharma India Ltd. authored by Rudra Shares and Stock Brokers Ltd and published by - Trendlyne research reports.
Item: AstraZeneca Pharma India Ltd.
Rating: 5
Author: Rudra Shares and Stock Brokers Ltd

Latest analyst research reports with target prices and PDF download for ASTRAZEN, BSE:506820 AstraZeneca Pharma India Ltd.

Search Inside the pdf :

AstraZeneca Pharma India Ltd.

08 Nov 2017

7943.00

-0.04%

ASTRAZENECA PHARMA I..

Buy: AstraZeneca Pharma India Ltd.

Rudra Shares and Stock Brokers Ltd

Company entered into Distribution Services Agreement with Dr. Reddy's Laboratories to distribute Saxagliptin and with Sun Pharma to distribute Dapagliflozin and Ticagrelor under different brand names. During the year, these partnerships have enabled company to...

AstraZeneca Pharma India Ltd. is trading below all available SMAs

Is AstraZeneca Pharma India Ltd. worth buying?

151 Votes:

Buy 71.52%

Sell 19.21%

Hold 9.27%